All 53 online GLP-1 clinics we review, scored

A cash-pay practice that publishes a price table for every partner pharmacy and dose tier, with no subscription: you pay once for each 8 to 10 week supply, plus a separate consult fee. Its independent record is thin, and BBB rates it D-.

A low-priced, heavily-credentialed option. Compounded semaglutide from $99/mo, reviewed within 24h by independent US board-certified physicians, dispensed by a LegitScript-certified 503A pharmacy with free overnight shipping and a 30-day money-back guarantee.

Publishes both the intro price and the ongoing one in the same breath ($139 the first month, then $199) and is one of the few here that will sell you brand-name Mounjaro® alongside compounded options.

A Michigan longevity clinic with named physicians that sells compounded GLP-1s at full dose and microdoses, plus monitored access to Wegovy and Zepbound. It prices only its 4-month plans up front.

A brand-name GLP-1 service that publishes both of its bills: a Ro Body membership from $74/mo on a plan prepaid annually, and medication at the manufacturer's self-pay price from $149/mo. It is rated A+ and accredited by BBB, and its terms make the paid membership fee non-refundable.

WeightWatchers' clinical membership, now with brand-name GLP-1s at self-pay prices: a $74 monthly membership on a 12-month plan that renews for another year, plus the medication billed on top. Board-certified clinicians and named medical groups, but BBB rates the company C-.

Names its dispensing pharmacy with a street address and a phone number, publishes its full price grid with the real charged total, and has 870 independent reviews behind it. Sold from $119/mo on a 12-month plan ($1,428 up front), and paying us a $100 commission per sale.

Compounded semaglutide from $49/mo (Fall sale rate on a cancel-anytime monthly plan; verify current pricing before purchase), Ozempic and Zepbound listed without saying whether they are brand-name or compounded, and a 90-day money-back guarantee.

An all-in-one telehealth shop (GLP-1 weight loss plus hair, sexual health and NAD+) with discreet delivery and pricing it shows up front, no insurance games.

Flat $99/mo compounded semaglutide with no membership fee and no long-term commitment, cancel anytime, plus a genuine oral (needle-free) route for both semaglutide and tirzepatide, which most budget clinics in this range don't offer.

An all-inclusive compounded GLP-1 plan that prints every billing term with its full charge and names its clinicians and pharmacy, from $99 a month on a year paid up front. Trustpilot has suspended its rating after removing fake reviews.

A clean, value-first option: compounded semaglutide from $125/mo (6-month plan), free 2-day shipping, though it does not name the pharmacy that fills prescriptions. Both GLP-1 injectables, nationwide.

One of the few clinics here that names its actual pharmacies and medical groups, publishes every plan length with its billing cadence, and bundles metabolic lab work every six months. But it's priced at the top of this set and it doesn't ship to 11 states.

A cash-pay GLP-1 program that prints the intro price and the ongoing one side by side ($104.50 for the first 4 weeks, then $209 every 4 weeks for compounded semaglutide), names its medical group and four dispensing pharmacies, and sells brand Ozempic® and Zepbound® alongside compounded options.

A membership plus pharmacy model with a live video visit, more than 400 named providers and per-dose prices for every GLP-1 it sells, including six brand-name drugs. The catch is that the membership and the medication are separate bills, and its own pages disagree about what the first month costs.

A Tampa telehealth company founded in 2004 that sells compounded semaglutide and tirzepatide as weekly injections or rapid-dissolve tablets. It publishes only the lowest monthly figure for each, from $89/mo on a 6-month supply, and not the total charged, the shorter plans or the shipping cost. Compounded medications are not FDA-approved.

Compounded semaglutide from $73/mo on its public homepage, which doesn't state the plan length, from a clinic that names neither its pharmacy, nor its medical group, nor the states it serves.

Both GLP-1 molecules in both routes plus three real brand names, and the most rigorously sourced medication-comparison page of any clinic we track. From a practice that publishes neither its pharmacy, nor the states it ships to, nor any refund terms behind a $2,094 upfront charge.

Weekly injections, daily oral drops, sublingual and pills, plus brand-name Wegovy/Zepbound, from a Utah-based provider with a real, disclosed company address.

A weight-loss app with a medical program on top: compounded GLP-1 plans at $249/mo, billed quarterly, after a $129 first month, with care and medication in that price, and a $129/mo care plan for brand-name drugs. It names no medical group and no pharmacy.

Two GLP-1 molecules in both injection and oral form plus cash-pay Ozempic and Zepbound, from $99/mo on the annual plan. From a site that publishes two contradictory price grids for the same medication and advertises a 4.9 rating on a Trustpilot profile holding zero reviews.

The GLP-1 arm of the LIV Body fitness brand. Compounded semaglutide from $99/mo and tirzepatide from $149 as one simple weekly injection, with no membership or contract, prescribed after an online medical assessment by OpenLoop Health's licensed providers, with free overnight shipping from a US-licensed pharmacy.

A clean, medically supervised on-ramp to GLP-1 weight loss with a personalized plan and an optional NAD+ add-on. Straightforward for first-timers.

A compounded GLP-1 plan with one of the clearest price lists here, from $99 a month on a year paid up front, sold alongside a peptide catalogue. Its sign-up page shows a 4.8 Trustpilot rating for a company Trustpilot has no page for.

Publishes a full price grid across six named compounding pharmacies, with compounded semaglutide from $73/mo on a $219 three-month plan. But the cheapest rate depends on a pharmacy its own terms say it cannot guarantee, and the BBB rates the company F.

Compounded semaglutide and tirzepatide as a weekly injection, medication included, from $69 a month on a twelve-month supply paid up front during a time-limited sale, with unlimited 24/7 messaging.

A longevity-minded option. GLP-1 treatment from $119/mo, the one GLP-1 price Oak publishes, after an async licensed-provider review, with free shipping, health coaching and optional NAD+/peptide add-ons.

The telehealth arm of a 20-year fitness brand. Compounded semaglutide from $141.50/mo, tirzepatide and a rare microdosing tier, managed entirely through the portal with no live appointment.

Compounded semaglutide and tirzepatide, plus HRT (estradiol and progesterone) on the same account, all after a licensed consult, in all 50 states.

Names 36 individual physicians and all five of its partner pharmacies, but it starts at $299/mo, its advertised rate climbs to $549 as your dose goes up without saying so on the page, and it displays a 4.9 rating its own Trustpilot profile puts at 3.9.

A coaching-first GLP-1 program that prescribes only brand-name medication through your commercial insurance. The $199/mo is a membership on a locked 3-month minimum, with medication and labs billed separately, and it does not accept uninsured patients or Medicare, Medicaid, Tricare or Kaiser members.

Publishes a full plan grid with 6- and 12-month totals and a named medical team, with 12,531 Trustpilot reviews at 4.4, but its own pages quote three different prices for the same drugs, it names no pharmacy and no medical group, and BBB rates it F with 234 complaints closed in three years.

A publicly traded telehealth company (NASDAQ: LFMD) prescribing only brand-name GLP-1s, including the Wegovy pill, Zepbound and Foundayo, at manufacturer cash prices. The $149 headline is the medication alone: a $149 monthly program fee sits on top, disclosed only in a footnote.

The high-touch option: a dedicated care team and unlimited 24/7 support guiding every step toward a 1-2 lb/week pace, with compounded semaglutide published at $199/mo on its own products page.

Compounded semaglutide from $149/month and tirzepatide from $187/month, each described as everything included, through a platform that names its prescribing network (Telegra MD) and its two fulfilment pharmacies.

A $199/month GLP-1 protocol that bundles a body-composition scanner and weekly physician-read scans. The most monitoring anyone here describes, sold by a clinic whose Trustpilot profile was removed for breaking Trustpilot's guidelines while its pages still display a Trustpilot score.

A pay-per-order compounded GLP-1 service with a full public price grid: $299 for 12 weeks of semaglutide at the lowest doses, rising to $499 at the highest, with no subscription. BBB rates the company F for unanswered complaints.

A rare needle-free option where the sublingual route is the cheaper one, $249/mo against $297 for injections, but billing and cancellation complaints keep its trust score honest.

One of the earliest GLP-1-focused telehealth brands. Plans include the medication, priced on two axes (insurance or cash, monthly or 12-month prepaid) and billed per 28-day cycle, with compounded semaglutide from $99/mo on the annual insurance plan.

A large compounded GLP-1 clinic that fronts $149 for the first month and bills $299 a month after that, names its medical groups and three pharmacies, and holds an open FDA warning letter plus a BBB F rating.

Cheap on paper at $69/mo. But it is the same company as Embody trading under a second name, and its "125k+ customers" claim sits beside a Trustpilot profile holding two reviews.

Named-drug pricing: $79/mo semaglutide on a 12-month plan paid in full, tirzepatide from $129/mo. Undercut by a Trustpilot rating Trustpilot itself has suspended for fake reviews.

Compounded tirzepatide at one flat rate for every dose, from $149.99 a month on a 12-month plan billed up front, plus five brand-name GLP-1s, from a clinic with an open FDA warning letter over its earlier weight-loss claims.

Compounded semaglutide as a weekly injection or a daily lozenge, but its two public price grids disagree: the injection is $129/mo on one page and from $149 on another, the lozenge $199 or from $99. It also carries an FDA warning letter over its compounded claims.

A membership plus medication program that prints both bills, names six compounding pharmacies and asks for a weekly check-in, with brand-name pills and injections alongside compounded ones. It holds an open FDA warning letter, and its own pages disagree about whether you can cancel once a program starts.

A household-name telehealth brand, now selling only brand-name GLP-1s: Wegovy, Zepbound, Ozempic, Mounjaro and Foundayo, with named medical groups and pharmacies. A $149 monthly membership sits on top of every medication price, and it holds two open FDA warning letters and a pending FTC lawsuit.

The format buffet (compounded semaglutide and tirzepatide as a weekly injection or a daily tablet, from $99 first month on the injectables) but the ongoing rate is published nowhere, and a thin independent track record with support complaints keeps its trust score in check.

A large compounded semaglutide and tirzepatide service (13,715 Trustpilot reviews at 4.6) that publishes no price before intake, carries an open FDA warning letter from September 2025 and an F rating at the BBB.

Three GLP-1 formats including an oral option. Undercut by an open FDA letter against the same legal entity that operates its own pricing page, and a refund policy that reprices rather than prorates.

A multi-specialty telehealth service with a $135/mo membership and medication billed on top, so compounded semaglutide really costs about $286/mo. It is under an open FDA warning letter over claims implying its compounded semaglutide is the same as Wegovy and Ozempic, and one of the quoted claims is still on its own pages.

A cash-pay compounded GLP-1 service that bundles the consult, medication and shipping into one package price. The price rises from $199 to $299 after the first month, BBB rates it F with a pattern-of-complaints alert, and it names neither its pharmacy nor its medical group.

A needle-free, oral-only route, compounded semaglutide and tirzepatide as dissolvable tablets, but premium-priced at $299/mo, with active Eli Lilly litigation and trust gaps that hold it back.